Pancreatic Cancer

Researchers have harnessed the ability of some molecules to vibrate strongly when stimulated by light, potentially laying the groundwork for a new approach to destroying cancer cells.

Researchers estimated the global lifetime risk for developing gastrointestinal cancer in 2020 was one in 12 people, while one in 16 people will die, with colorectal cancer presenting the highest risk compared with other GI cancers.

Cancer research and advocacy funding disproportionately skewed toward certain subtypes, leaving many cancers with high mortality rates and those affecting Black patients underfunded, study results in JCO Oncology Practice showed.

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

A sound wave technique pioneered at University of Michigan has exhibited preliminary efficacy as a treatment for liver cancer.

Cancer mortality in the U.S. is projected to decline again in 2024, but the number of new diagnoses should top 2 million for the first time, an annual report from the American Cancer Society revealed.

Adults with type 2 diabetes who use GLP-1 receptor agonists do not have an increased short-term risk for pancreatic cancer, according to findings published in JAMA Network Open.

The Advanced Research Projects Agency for Health, or ARPA-H, awarded $45 million to fast track the development of a “closed loop” implant for continuous monitoring of patients with cancer undergoing treatment with immunotherapy.

Results of a phase 1 trial for a vaccine targeting micrometastatic disease markers in patients already treated for pancreatic or colorectal cancer showed potential in preventing recurrence, according to a study in Nature Medicine.

Alec Kimmelman, MD, PhD, has been appointed director of Perlmutter Cancer Center at NYU Langone Health.